AVM Biotechnology, Inc
October 18, 2023
Franciscan C
Oncology
Mobilizing endogenous bi-specific Natural-Killer T-like cells that penetrate solid tumors and blood cancers
Company Type
Privately Funded
Website
http://www.avmbiotech.com
CEO/Top Company Official
Theresa Deisher
Lead Product in Development
AVM0703
Number Of Unlicensed Products
3
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)